[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 62, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., CA, CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 84541, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 171407, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & VP of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 58, "title": "Consultant", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 2, "previousClose": 45.72, "open": 44.93, "dayLow": 40.3047, "dayHigh": 46.7151, "regularMarketPreviousClose": 45.72, "regularMarketOpen": 44.93, "regularMarketDayLow": 40.3047, "regularMarketDayHigh": 46.7151, "beta": 0.494, "volume": 79505, "regularMarketVolume": 79505, "averageVolume": 112627, "averageVolume10days": 65350, "averageDailyVolume10Day": 65350, "bid": 41.96, "ask": 42.52, "bidSize": 100, "askSize": 100, "marketCap": 300283680, "fiftyTwoWeekLow": 0.93, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 38.4688, "twoHundredDayAverage": 17.323345, "currency": "USD", "enterpriseValue": 236724816, "forwardPE": -9.52164, "floatShares": 2194414, "sharesOutstanding": 7043990, "sharesShort": 137699, "sharesShortPriorMonth": 176685, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0195, "heldPercentInsiders": 0.24590999, "heldPercentInstitutions": 0.73507005, "shortRatio": 1.49, "shortPercentOfFloat": 0.0287, "impliedSharesOutstanding": 7183820, "bookValue": 8.274, "priceToBook": 5.05197, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1068069, "trailingEps": -0.46, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 23.449198, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "DRUG", "underlyingSymbol": "DRUG", "shortName": "Bright Minds Biosciences Inc.", "longName": "Bright Minds Biosciences Inc.", "firstTradeDateEpochUtc": 1616419800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "7de90f41-6566-3a5c-a990-c3e8fec46e3b", "messageBoardId": "finmb_691048918", "gmtOffSetMilliseconds": -18000000, "currentPrice": 41.8, "targetHighPrice": 92.91517, "targetLowPrice": 92.91517, "targetMeanPrice": 92.91517, "targetMedianPrice": 92.91517, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 57896664, "totalCashPerShare": 8.219, "totalDebt": 182733, "quickRatio": 125.592, "currentRatio": 126.151, "debtToEquity": 0.316, "returnOnAssets": -0.04926, "returnOnEquity": -0.03345, "freeCashflow": -1400343, "operatingCashflow": -2522493, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]